Gutfeld Orit, Kretzler Annette E, Kashani Rojano, Tatro Daniel, Balter James M
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109-5010, USA.
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1596-601. doi: 10.1016/j.ijrobp.2008.12.025.
To evaluate the impact of rotational setup errors on dose distribution in spinal stereotactic body radiotherapy (SBRT).
Thirty-nine cone beam computed tomography (CBCT) scans from 16 SBRT treatment courses were analyzed. Alignment (including rotation) to the treatment planning computed tomography was performed, followed by translational alignment that reproduced the actual positioning. The planned fluence was then applied to determine the delivered dose to the targets and organs at risk.
The mean planning target volume (PTV) was 71.01 mL (SD +/- 60.05; range, 22.62-250.65 mL). Prescribed dose (to the 62-82% isodose) was 14-30 Gy in one to six fractions. The average rotational displacements were 0.38 +/- 1.21, 1.12 +/- 1.82, and -0.51 +/- 2.0 degrees with maximal rotations of -4.29, 5.76, and -6.64 degrees along the x (pitch), y (yaw), and z (roll) axes, respectively. PTV coverage changed by an average of -0.07 Gy (SD +/- 0.20 Gy) between the rotated and the original plan, representing 0.92% of prescription dose (SD +/- 2.65%). For the spinal cord, planned with 2-mm expansion to create a planning organ at risk volume (PRV), the difference in minimum dose to the upper 10% of the PRV volume was 0.03 +/- 0.3 Gy (maximum, 0.9 Gy). Other organs at risk saw insignificant changes in dose.
PRV expansion generally assures safe treatment delivery in the face of typically encountered rotations. Given the variability of delivered dose within this expansion for certain cases, caution should be taken to properly interpret doses to the cord when considering clinical dose limits.
评估旋转设置误差对脊柱立体定向体部放射治疗(SBRT)中剂量分布的影响。
分析了16个SBRT治疗疗程的39次锥形束计算机断层扫描(CBCT)。先将其与治疗计划计算机断层扫描进行配准(包括旋转),然后进行平移配准以重现实际定位。接着应用计划的注量来确定靶区和危及器官的实际剂量。
平均计划靶体积(PTV)为71.01 mL(标准差±60.05;范围,22.62 - 250.65 mL)。处方剂量(至62% - 82%等剂量线)为14 - 30 Gy,分1至6次给予。平均旋转位移分别为0.38±1.21、1.12±1.82和 - 0.51±2.0度,沿x(俯仰)、y(偏航)和z(横滚)轴的最大旋转分别为 - 4.29、5.76和 - 6.64度。旋转后的计划与原始计划相比,PTV覆盖剂量平均变化为 - 0.07 Gy(标准差±0.20 Gy),占处方剂量的0.92%(标准差±2.65%)。对于脊髓,计划时外放2 mm以创建计划危及器官体积(PRV),PRV体积上10%的最小剂量差异为0.03±0.3 Gy(最大为0.9 Gy)。其他危及器官的剂量变化不显著。
面对通常遇到的旋转情况,PRV外放一般可确保安全的治疗实施。鉴于某些情况下在此外放范围内实际剂量存在变异性,在考虑临床剂量限制时,应谨慎解读脊髓剂量。